Complement Factor H (CFH) is a pivotal regulator of the complement system, integral to maintaining immune homeostasis and protecting host tissues from undue complement‐mediated damage. By inhibiting ...
Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to respond well to standard drug .
The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...
16don MSN
Rallybio shares successful early-stage results for rare disease drug; new trial set for late 2026
Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) ...
A team led by the University of Sydney has identified red blood cell rupture at dying endothelial sites as a primary driver of microvascular obstruction in COVID-19, bypassing the expected role of ...
Myasthenia Gravis (MG) is a rare autoimmune disease in which the immune system attacks the connection between nerves and ...
News-Medical.Net on MSN
Dietary fat ratios impact the strength of immune cells and ability to fight disease
The types of fats we consume directly impacts the survival and strength of the body's immune cells and ability to fight disease, researchers have found. A University of Queensland team led an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results